Skip to main content

UBS Group AG

Position in BLTE — Belite Bio, Inc

CIK 1610520 ZURICH, V8

Position in BLTE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$34,644,930
-$87,862,227 QoQ
Shares Held
224,989
-70.7% QoQ
Ownership
0.559%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 81 holders
Holding Since
Jun 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BLTE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. BLTE ranks #49 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BLTE

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $34,644,930 224,989
2026-03-31 $122,507,157 768,359
2025-12-31 $20,595,168 128,752
2025-09-30 $838,716 11,334
2025-06-30 $136,056 2,358
2025-03-31 $36,486 551
2024-12-31 $770,261 12,207
2024-09-30 $6,000 128
2023-12-31 $15,921 348
2023-09-30 $28,123 883
2023-06-30 $4,287 300
2023-03-31 $3,588 120
2022-12-31 $127,121 4,217
2022-06-30 $21,268 683